American Healthcare REIT, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held on June 24, 2026. The filing details the voting results for three proposals submitted to shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Three proposals were voted upon at the annual meeting:
- Proposal 1 (Election of Directors): All nine nominees were elected. Notable voting results included Mathieu B. Streiff, who received 99,168,560 shares "For" and 58,312,003 shares "Withheld," and Jeffrey T. Hanson, who received 150,602,098 shares "For" and 6,878,465 shares "Withheld."
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2026. The vote was 172,002,161 "For," 1,383,331 "Against," and 192,150 "Abstained."
- Proposal 3 (Executive Compensation): The advisory vote to approve executive compensation for the year ended December 31, 2025, was approved. The vote was 152,134,858 "For," 5,019,014 "Against," and 326,691 "Abstained."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the standard disclosure of the voting process.
Key Facts for Investor Verification
- Verify the specific reasons for the significant number of shares withheld for director Mathieu B. Streiff (58.3 million) compared to other nominees.
- Confirm the total number of shares outstanding and the percentage of votes cast versus total eligible shares to assess shareholder engagement levels.
- Review the definitive proxy statement (Schedule 14A filed April 9, 2026) for detailed biographies of the elected directors and the specific compensation metrics approved in Proposal 3.
- Note that Jeffrey T. Hanson is serving as Interim Chief Executive Officer and President as of the signing date (June 25, 2026).